Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muscle maturation: implications for gene therapy

J C van Deutekom1, E P Hoffman, J Huard

  • 1Dept. of Orthopaedic Surgery, Children's Hospital of Pittsburgh, PA 15213, USA.

Molecular Medicine Today
|June 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of losartan or angiotensin II receptor antagonists on cartilage: a systematic review.

Osteoarthritis and cartilage·2022
Same author

[Impact of the Lubrizol Rouen plant fire of September 26, 2019 on ophthalmic emergency room visits].

Journal francais d'ophtalmologie·2021
Same author

Bone morphogenetic proteins for articular cartilage regeneration.

Osteoarthritis and cartilage·2018
Same author

αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis.

Nature communications·2017
Same author

Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA.

Neuromuscular disorders : NMD·2017
Same author

Evolving paradigms in clinical pharmacology and therapeutics for the treatment of Duchenne muscular dystrophy.

Clinical pharmacology and therapeutics·2016
Same journal

Have tumor cells learnt from microorganisms how to fool the immune system? Escape from immune surveillance of tumors and microorganisms: emerging mechanisms and shared strategies.

Molecular medicine today·2001
Same journal

Molecular signalling in cardiovascular biology: from molecules to man. International symposium organized by the centre for cardiovascular biology and medicine, King's College, London.

Molecular medicine today·2001
Same journal

Is successful gene therapy for retinal disease in sight?

Molecular medicine today·2001
Same journal

New imaging techniques for early diagnosis of Alzheimer's disease.

Molecular medicine today·2001
Same journal

Knocking out NEMO.

Molecular medicine today·2001
Same journal

Clinical gene therapy back in the race.

Molecular medicine today·2001
See all related articles

Gene therapy using viral vectors shows promise for skeletal muscle disorders. However, challenges exist in efficiently delivering genes to mature muscle fibers, prompting research into novel approaches to overcome these barriers.

Area of Science:

  • Biomedical research
  • Gene therapy
  • Molecular biology

Background:

  • Skeletal muscle is a key target for gene therapy applications, addressing both muscle-specific and systemic conditions.
  • Various viral vector systems, including retroviral, adenoviral, and herpes simplex viral vectors, have been explored for gene transfer into skeletal muscle.
  • Despite advancements, significant obstacles hinder the efficiency of muscle-based viral gene therapy.

Purpose of the Study:

  • To elucidate the reasons behind the inefficient transduction of mature muscle fibers by certain viral vectors.
  • To present and discuss emerging strategies designed to surmount the barriers in viral gene delivery to skeletal muscle.

Main Methods:

  • Review and analysis of existing literature on viral vector-mediated gene transfer in skeletal muscle.

Related Experiment Videos

  • Discussion of the biological and mechanical factors limiting viral vector efficacy.
  • Exploration of novel gene delivery techniques and vector modifications.

    • Main Results:

    • Identification of specific limitations in current viral vectors that prevent efficient gene transfer into terminally differentiated muscle fibers.
    • Outlined several innovative approaches aimed at enhancing gene delivery efficiency and overcoming transduction barriers.
    • Highlighted the potential of these new strategies to advance skeletal muscle gene therapy.

    Conclusions:

    • Understanding the limitations of viral vectors in targeting mature muscle fibers is crucial for improving gene therapy outcomes.
    • Newer methodologies show promise in enhancing gene delivery, paving the way for more effective skeletal muscle gene therapies.
    • Continued research into advanced vector systems and delivery strategies is essential for realizing the full potential of muscle-targeted gene therapy.